ID GSPB_STRGN Reviewed; 3072 AA. AC Q939N5; DT 14-DEC-2011, integrated into UniProtKB/Swiss-Prot. DT 01-DEC-2001, sequence version 1. DT 27-MAR-2024, entry version 79. DE RecName: Full=Platelet binding protein GspB; DE AltName: Full=Adhesin GspB {ECO:0000305}; DE AltName: Full=Serine-rich adhesin for platelets; DE AltName: Full=Serine-rich repeat protein GspB; DE Flags: Precursor; GN Name=gspB; OS Streptococcus gordonii. OC Bacteria; Bacillota; Bacilli; Lactobacillales; Streptococcaceae; OC Streptococcus. OX NCBI_TaxID=1302; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], SUBCELLULAR LOCATION, AND DISRUPTION RP PHENOTYPE. RC STRAIN=M99; RX PubMed=12010500; DOI=10.1046/j.1365-2958.2002.02949.x; RA Bensing B.A., Sullam P.M.; RT "An accessory sec locus of Streptococcus gordonii is required for export of RT the surface protein GspB and for normal levels of binding to human RT platelets."; RL Mol. Microbiol. 44:1081-1094(2002). RN [2] RP S.GORDONII IN INFECTIVE ENDOCARDITIS. RX PubMed=8366515; DOI=10.1099/00222615-39-3-179; RA Douglas C.W., Heath J., Hampton K.K., Preston F.E.; RT "Identity of viridans streptococci isolated from cases of infective RT endocarditis."; RL J. Med. Microbiol. 39:179-182(1993). RN [3] RP GLYCOSYLATION, AND SUBCELLULAR LOCATION. RC STRAIN=M99; RX PubMed=14729688; DOI=10.1128/jb.186.3.638-645.2004; RA Bensing B.A., Gibson B.W., Sullam P.M.; RT "The Streptococcus gordonii platelet binding protein GspB undergoes RT glycosylation independently of export."; RL J. Bacteriol. 186:638-645(2004). RN [4] RP EXPORT VIA THE ACCESSORY SECA2/SECY2 SYSTEM. RC STRAIN=M99; RX PubMed=15049820; DOI=10.1111/j.1365-2958.2004.03978.x; RA Takamatsu D., Bensing B.A., Sullam P.M.; RT "Genes in the accessory sec locus of Streptococcus gordonii have three RT functionally distinct effects on the expression of the platelet-binding RT protein GspB."; RL Mol. Microbiol. 52:189-203(2004). RN [5] RP GLYCOSYLATION OF SER-RICH REGIONS. RC STRAIN=M99; RX PubMed=15489421; DOI=10.1128/jb.186.21.7100-7111.2004; RA Takamatsu D., Bensing B.A., Sullam P.M.; RT "Four proteins encoded in the gspB-secY2A2 operon of Streptococcus gordonii RT mediate the intracellular glycosylation of the platelet-binding protein RT GspB."; RL J. Bacteriol. 186:7100-7111(2004). RN [6] RP DISCUSSION OF SEQUENCE. RX PubMed=19202081; DOI=10.1099/mic.0.025221-0; RA Zhou M., Wu H.; RT "Glycosylation and biogenesis of a family of serine-rich bacterial RT adhesins."; RL Microbiology 155:317-327(2009). RN [7] RP FUNCTION, DOMAIN, AND DISRUPTION PHENOTYPE. RC STRAIN=M99; RX PubMed=20714350; DOI=10.1371/journal.ppat.1001044; RA Sanchez C.J., Shivshankar P., Stol K., Trakhtenbroit S., Sullam P.M., RA Sauer K., Hermans P.W., Orihuela C.J.; RT "The pneumococcal serine-rich repeat protein is an intra-species bacterial RT adhesin that promotes bacterial aggregation in vivo and in biofilms."; RL PLoS Pathog. 6:E1001044-E1001044(2010). RN [8] RP INTERACTION WITH ASP2 AND ASP3. RX PubMed=21531800; DOI=10.1128/jb.00057-11; RA Yen Y.T., Seepersaud R., Bensing B.A., Sullam P.M.; RT "Asp2 and Asp3 interact directly with GspB, the export substrate of the RT Streptococcus gordonii accessory Sec System."; RL J. Bacteriol. 193:3165-3174(2011). RN [9] RP GLYCOSYLATION OF SER-RICH REGIONS. RC STRAIN=M99; RX PubMed=26884191; DOI=10.1073/pnas.1600494113; RA Chen Y., Seepersaud R., Bensing B.A., Sullam P.M., Rapoport T.A.; RT "Mechanism of a cytosolic O-glycosyltransferase essential for the synthesis RT of a bacterial adhesion protein."; RL Proc. Natl. Acad. Sci. U.S.A. 113:E1190-E1199(2016). RN [10] RP X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 245-604, FUNCTION, MUTAGENESIS OF RP TYR-443; ARG-484 AND TYR-485, AND INTERACTION WITH HUMAN GP1BA. RX PubMed=21765814; DOI=10.1371/journal.ppat.1002112; RA Pyburn T.M., Bensing B.A., Xiong Y.Q., Melancon B.J., Tomasiak T.M., RA Ward N.J., Yankovskaya V., Oliver K.M., Cecchini G., Sulikowski G.A., RA Tyska M.J., Sullam P.M., Iverson T.M.; RT "A structural model for binding of the serine-rich repeat adhesin GspB to RT host carbohydrate receptors."; RL PLoS Pathog. 7:E1002112-E1002112(2011). CC -!- FUNCTION: Plays a role in virulence and host-pathogen interactions. CC Mediates binding to human platelets via interaction with the human cell CC surface glycoprotein GP1BA (PubMed:21765814). Plays a positive role in CC biofilm formation, possibly by self-association via the basic region CC (BR) (PubMed:20714350). {ECO:0000269|PubMed:20714350, CC ECO:0000269|PubMed:21765814}. CC -!- SUBUNIT: Both SSR domains in the unglycosylated protein bind to Asp2 CC and Asp3; glycosylated protein binds less well. Interacts with the CC human cell surface glycoprotein GP1BA. {ECO:0000269|PubMed:21531800, CC ECO:0000269|PubMed:21765814}. CC -!- INTERACTION: CC Q939N5; Q9AET8: asp2; NbExp=4; IntAct=EBI-6414561, EBI-6414583; CC Q939N5; Q9AET7: asp3; NbExp=4; IntAct=EBI-6414561, EBI-6414568; CC -!- SUBCELLULAR LOCATION: Secreted, cell wall {ECO:0000269|PubMed:12010500, CC ECO:0000269|PubMed:14729688}; Peptidoglycan-anchor CC {ECO:0000269|PubMed:12010500, ECO:0000269|PubMed:14729688}. CC Note=Exported by the accessory SecA2/SecY2 protein translocation CC apparatus. {ECO:0000269|PubMed:12010500}. CC -!- DOMAIN: Has a short and long Ser-rich region with a basic region CC between them. The SRR domains themselves are comprised of inexact CC repeats of SASESASTSASV. SSR1 has 6 repeats, SSR2 has 200. The Ser-rich CC regions are both glycosylated. The basic region (BR) binds to whole CC cell lysates of wild-type but not bacteria deleted of this gene; it CC also recognizes whole cell lysates of S.aureus strain ISP479C probably CC via SraP, but not lysates of S.pneumoniae TIGR4 (PubMed:20714350). The CC predicted pI of the basic region is 9.51 (PubMed:19202081). CC {ECO:0000269|PubMed:20714350, ECO:0000303|PubMed:19202081}. CC -!- PTM: Proteolytically cleaved by a metalloprotease. {ECO:0000250}. CC -!- PTM: Both SSR1 and SSR2 domains are glycosylated (Probable). A CC truncated derivative (residues 1-2062) contains 105 nmol per nmol of CC protein, suggesting at least 10% of the apparent molecular weight is CC due to carbohydrates (PubMed:14729688). Glucose and N-acetylglucosamine CC are present in a ratio of 30:73 residues per truncated polypeptide, as CC well as minor amounts of galactose and N-acetylgalactosamine CC (PubMed:14729688). Glycosylation occurs intracellularly in the Ser-rich CC regions SSR1 and SSR2 (PubMed:14729688, PubMed:15489421). Glycosylation CC of SSR2 domain may be required to prevent aggregation of GspB CC (Probable). It is probable that most of the Ser residues in SSR1 and CC SSR2 are O-GlcNAcylated. Sequential glycosylation by sugar transferases CC are able to generate complex sugar polymorphisms (By similarity). CC {ECO:0000250|UniProtKB:A0A0H2URK1, ECO:0000269|PubMed:14729688, CC ECO:0000269|PubMed:15489421, ECO:0000305|PubMed:14729688, CC ECO:0000305|PubMed:15489421, ECO:0000305|PubMed:26884191}. CC -!- DISRUPTION PHENOTYPE: Loss of adherence to human platelet cells CC (PubMed:12010500). Decrease in early biofilm formation CC (PubMed:20714350). {ECO:0000269|PubMed:12010500, CC ECO:0000269|PubMed:20714350}. CC -!- MISCELLANEOUS: S.gordonii, a commensal oral cavity bacteria, is among CC the bacteria most frequently identified as being the primary CC etiological agents of subacute infective endocarditis (found in 13% of CC cases). {ECO:0000269|PubMed:8366515}. CC -!- SIMILARITY: Belongs to the serine-rich repeat protein (SRRP) family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AY028381; AAL13053.1; -; Genomic_DNA. DR PDB; 3QC5; X-ray; 1.40 A; X=245-604. DR PDB; 3QC6; X-ray; 1.90 A; X=245-604. DR PDB; 5IUC; X-ray; 1.25 A; A/B=399-521. DR PDB; 6EF7; X-ray; 1.03 A; A=399-521. DR PDB; 6EF9; X-ray; 1.30 A; A=398-521. DR PDB; 6EFA; X-ray; 1.60 A; A=399-601. DR PDBsum; 3QC5; -. DR PDBsum; 3QC6; -. DR PDBsum; 5IUC; -. DR PDBsum; 6EF7; -. DR PDBsum; 6EF9; -. DR PDBsum; 6EFA; -. DR SMR; Q939N5; -. DR IntAct; Q939N5; 2. DR UniLectin; Q939N5; -. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-KW. DR GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW. DR Gene3D; 2.60.40.3260; -; 1. DR Gene3D; 2.60.40.4140; -; 1. DR Gene3D; 3.10.20.890; -; 1. DR InterPro; IPR044024; aRib. DR InterPro; IPR022263; KxYKxGKxW. DR InterPro; IPR019931; LPXTG_anchor. DR InterPro; IPR026465; Ser_adhes_glycop_N. DR NCBIfam; TIGR03715; KxYKxGKxW; 1. DR NCBIfam; TIGR01167; LPXTG_anchor; 1. DR NCBIfam; TIGR04224; ser_adhes_Nterm; 1. DR PANTHER; PTHR12239; PROTEIN CBG20215-RELATED; 1. DR PANTHER; PTHR12239:SF41; TOLA PROTEIN; 1. DR Pfam; PF18938; aRib; 1. DR Pfam; PF00746; Gram_pos_anchor; 1. DR Pfam; PF19258; KxYKxGKxW_sig; 1. DR PROSITE; PS50847; GRAM_POS_ANCHORING; 1. PE 1: Evidence at protein level; KW 3D-structure; Cell adhesion; Cell wall; Glycoprotein; Peptidoglycan-anchor; KW Secreted; Signal; Virulence. FT SIGNAL 1..85 FT /evidence="ECO:0000255" FT CHAIN 86..3041 FT /note="Platelet binding protein GspB" FT /id="PRO_0000414192" FT PROPEP 3042..3072 FT /note="Removed by sortase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00477" FT /id="PRO_0000414193" FT REGION 117..147 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 123..236 FT /note="Ser-rich region 1 (SSR1)" FT REGION 182..254 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 237..603 FT /note="Basic region (BR)" FT REGION 604..3028 FT /note="Ser-rich region 2 (SSR2)" FT REGION 876..909 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 936..969 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1024..2085 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 2106..2139 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 2173..2223 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 2250..2595 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 2625..2967 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 3014..3045 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 3038..3042 FT /note="LPXTG sorting signal" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00477" FT COMPBIAS 182..237 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 3014..3044 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT SITE 443 FT /note="Important for interaction with host glycoprotein and FT virulence" FT SITE 484 FT /note="Important for interaction with host glycoprotein and FT virulence" FT SITE 485 FT /note="Important for interaction with host glycoprotein and FT virulence" FT MOD_RES 3041 FT /note="Pentaglycyl murein peptidoglycan amidated threonine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00477" FT MUTAGEN 443 FT /note="Y->F: Strongly reduced interaction with GP1BA FT carbohydrate chains." FT /evidence="ECO:0000269|PubMed:21765814" FT MUTAGEN 484 FT /note="R->E: Strongly reduced interaction with GP1BA FT carbohydrate chains. Strongly reduced platelet binding." FT /evidence="ECO:0000269|PubMed:21765814" FT MUTAGEN 485 FT /note="Y->F: Strongly reduced interaction with GP1BA FT carbohydrate chains." FT /evidence="ECO:0000269|PubMed:21765814" FT STRAND 247..250 FT /evidence="ECO:0007829|PDB:3QC5" FT STRAND 253..257 FT /evidence="ECO:0007829|PDB:3QC5" FT STRAND 263..272 FT /evidence="ECO:0007829|PDB:3QC5" FT TURN 273..275 FT /evidence="ECO:0007829|PDB:3QC5" FT STRAND 277..284 FT /evidence="ECO:0007829|PDB:3QC5" FT STRAND 291..299 FT /evidence="ECO:0007829|PDB:3QC5" FT STRAND 303..310 FT /evidence="ECO:0007829|PDB:3QC5" FT STRAND 316..319 FT /evidence="ECO:0007829|PDB:3QC6" FT STRAND 328..333 FT /evidence="ECO:0007829|PDB:3QC5" FT STRAND 338..346 FT /evidence="ECO:0007829|PDB:3QC5" FT STRAND 351..364 FT /evidence="ECO:0007829|PDB:3QC5" FT TURN 368..370 FT /evidence="ECO:0007829|PDB:3QC6" FT HELIX 375..377 FT /evidence="ECO:0007829|PDB:3QC5" FT TURN 379..382 FT /evidence="ECO:0007829|PDB:3QC5" FT STRAND 386..395 FT /evidence="ECO:0007829|PDB:3QC5" FT STRAND 404..406 FT /evidence="ECO:0007829|PDB:6EF7" FT STRAND 409..414 FT /evidence="ECO:0007829|PDB:6EF7" FT STRAND 418..426 FT /evidence="ECO:0007829|PDB:6EF7" FT HELIX 434..436 FT /evidence="ECO:0007829|PDB:6EF7" FT STRAND 438..440 FT /evidence="ECO:0007829|PDB:6EF7" FT STRAND 442..446 FT /evidence="ECO:0007829|PDB:6EF7" FT STRAND 455..461 FT /evidence="ECO:0007829|PDB:6EF7" FT STRAND 464..472 FT /evidence="ECO:0007829|PDB:6EF7" FT STRAND 475..477 FT /evidence="ECO:0007829|PDB:3QC5" FT STRAND 480..487 FT /evidence="ECO:0007829|PDB:6EF7" FT STRAND 495..497 FT /evidence="ECO:0007829|PDB:6EF7" FT HELIX 499..508 FT /evidence="ECO:0007829|PDB:6EF7" FT STRAND 515..521 FT /evidence="ECO:0007829|PDB:6EF7" FT STRAND 531..534 FT /evidence="ECO:0007829|PDB:3QC5" FT HELIX 541..554 FT /evidence="ECO:0007829|PDB:3QC5" FT HELIX 560..562 FT /evidence="ECO:0007829|PDB:3QC5" FT HELIX 564..566 FT /evidence="ECO:0007829|PDB:3QC5" FT HELIX 568..571 FT /evidence="ECO:0007829|PDB:3QC5" FT STRAND 572..574 FT /evidence="ECO:0007829|PDB:3QC5" FT STRAND 580..584 FT /evidence="ECO:0007829|PDB:3QC5" FT STRAND 589..592 FT /evidence="ECO:0007829|PDB:3QC5" FT TURN 595..597 FT /evidence="ECO:0007829|PDB:3QC5" FT STRAND 598..601 FT /evidence="ECO:0007829|PDB:3QC5" SQ SEQUENCE 3072 AA; 285769 MW; 0B148372697CF7F2 CRC64; MFFKRQKGQY HEVERVTRFK LIKSGKHWLR AATSQFGLLR LMKGSDVSST EVKVVEEQSV EKSGLNYLKG IIATGAVLGG AVVTSSSVYA EEEQAHEKVI DTRDVLATRG EAVLSEEAAT TLSSTEANPV ESLSDTLSAS ESTSASSSVS TSISVSESFS VSGSLSYSTS LSQSVSASAS ASESLSVSSS ASDSVSASTS TSASASQSVS ASQKSTISTS ESTRSESSQQ STEASSQTGR RRTRRAVTES APNVEYHDVK GDMIQSVTTS FDDTSRLLTW TINLTPRQVK SNLGALVSIS GNQETRTVTI NGKNAANGGV YNSGGAWNLY TGESVNNNVL RITTQVNDTG GEVKLGLRLV TSDKKITKTN LPLEFSQVAA TTNGSWDKAG YNTTIVEKDT ERPVVNVPSE ITVYRGESFE YFATVTDNSN AFDLAKTVVR WLYNNQPGRG TEWLQYSVTQ VGNQLKVRIF GNVPIDTTIG DYTRYVVATD AAGNVNATQT EMGNAAVDKT SVNGQFKLII RFRIKTPENT VFVNNPNQLT EVEKNLVREA VKKSNPDLRA QDVLNSNYVT GITVSNNGTT TITYRDGRKD IIDGSKFIDT RAGSISKSQS TSNSISVSLS KSESASASLV TSKLNSISSS ASVSASTSIS TSGSVSASES ASTSSSVSAS ESASTSASVS ASESASTSAS VSASTSASTS ASVSASTSAS TSASTSASKS ASTSASVSAS TSASTSASVS ASESASTSAS VSASTSASTS ASVSASTSAS TSASVSASES ASTSASVSAS TSASTSASVS ASESASTSAS VSASTSASTS ASVSASASAS TSASVSASTS ASTSASVSAS ASASTSASVS ASTSASTSAS VSASESASTS ASVSASESAS TSASVSASES ASTSASVSAS ESASTSASVS ASTSASTSAS VSASESASTS ASVSASESAS TSASVSASES ASTSASVSAS ESASTSASVS ASTSASTSAS VSASTSASTS ASVSASTSAS TSASVSASTS ASTSASVSAS ESASTSASVS ASESASTSAS VSASTSASTS ASVSASESAS TSASVSASES ASTSASESAS ESASTSASVS ASESASTSAS VSASESSSTS ASVSASESSS TSASVSASES ASTSASVSAS ESASTSASES ASESASTSAS VSASESASTS ASVSASESAS TSASVSASES VSTSASVSAS ESASTSASVS ASESASTSAS ESASESASTS ASVSASESAS TSASVSASES ASTSASVSAS TSASTSASVS ASESASTSAS VSASESASTS ASVSASESAS TSASVSASES VSTSASVSAS ESASTSASVS ASESASTSAS ESASESASTS ASVSASESAS TSASVSASES ASTSASVSAS TSASTSASVS ASESASTSAS VSASESASTS ASVSASESAS TSASVSASTS ASTSASVSAS ESASTSTSVS TSTSASTSAS VSASESASTS ASVSASESAS TSASVSASTS ASTSASVSAS ESASTSASVS ASESASTSAS VSASESASTS ASVSASESAS TSASVSASTS ASTSASVSAS ESASTSASVS ASESASTSAS VSASESASTS ASVSASESAS TSASVSASES ASTSASVSAS ESASTSASVS ASESASTSAS VSASESASTS ASVSASESAS TSASVSASES ASTSASVSAS ESASTSASVS ASESASTSAS VSASESASTS ASVSASESAS TSASVSASES ASTSASVSAS ESASTSASVS ASESASTSAS VSASESASTS ASVSASESAS TSASVSASES ASTSASVSAS ESASTSASVS ASESASTSAS VSASESASTS ASVSASESAS TSASVSASES ASTSASVSAS TSTSTSASVS ASESASTSAS VSASESASTS ASVSASESAS TSASVSASES ASTSASVSAS ESASTSASVS ASESASTSAS VSASESASTS ASVSASESAS TSASVSASES ASTSASVSAS TSASTSASVS ASESASTSAS VSASESASTS ASVSASESAS TSASVSASES ASTSASVSAS ESASTSASVS ASESASTSAS VSASESASTS ASVSASESAS TSASVSASKS ASTSESASTS ASVSASESAS TSASVSASES ASTSASVSAS ESVSTSASVS ASDSASISAS VLASESASTS ASVSASESAS TSASVSASES ASTSASVSAS ESASTSSSVS ASESASTSAS VSASESASTS ASVSASTSAS TSASVSASES ASTSASVSAS ESASTSASVS ASESASTSAS VSASESASTS ASVSASESAS TSASVSASES ASTSASVSAS ESASTSASVS ASTSASTSAS VSASESASTS ASVSSSESAS TSASVSASES ASTSASVSAS ESASTSASVS ASESASTSAS VSASESASTS ASVSASTSAS TSASVSASES ASTSASVSAS ESASTSASVS ASESASTSAS VSASESASTS ASVSASTSAS TSASVSASES ASTSASVSAS ESASTSASVS ASTSASTSAS VSASESASTS ASVSASESAS TSASVSASES ASTSASVSAS ESASTSASVS ASESASTSAS VSASESASTS ASVSASESAS TSASVSASMS ASTSASVSVS ESTSTSASVS ANESASTSAS VSASESASTS ASVSASESAS TSASVSASES ASTSASVSAS ESASTSASVS ASESASTSAS VSASESASTS ASVSASESAS TSASVSASES ASTSASVSAS ESASTSASVS ASTSASTSAS VSANESASTS ASVSASESAS TSASVSASES ASTSASVSAS ESASTSASVS ASESASTSAS VSASTSASTS ASVSANESAS TSASVSASES ASTSASVSAS ESASTSASVS ASESASTSAS VSASESASTS ASVSASTSAS TSASVSASES ASTSASASAS ESASTSASVS ASESASTSAS VSASESASTS ASVSASESAS TNASVSVSES MSVSESLSLS ISTSVLHSQL NDIYESELYS LSLSESLSAS QSLSQSLSES QSSSASQSMH DRISKGQLPR TGESENKASI LALGLGALGL AFKKRKKNES ED //